Literature DB >> 19911998

Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity.

Chandy C John1, Micah Niermann, Bazak Sharon, Marnie L Peterson, David M Kranz, Patrick M Schlievert.   

Abstract

Staphylococcal toxic shock syndrome (TSS) has rarely been reported without rash and desquamation. This study describes a patient who met all criteria for TSS except erythroderma and desquamation. The associated staphylococcal superantigen was enterotoxin B. We demonstrate that erythroderma depends on preexisting T cell hypersensitivity amplified by superantigenicity.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19911998      PMCID： PMC2787872          DOI： 10.1086/648441

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Toxic shock syndrome without rash in a young child: link with syndrome of hemorrhagic shock and encephalopathy?

Authors:  S Van Lierde; W J van Leeuwen; J Ceuppens; L Cornette; P Goubau; J Van Eldere
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

3.  Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists.

Authors:  Rebecca A Buonpane; Hywyn R O Churchill; Beenu Moza; Eric J Sundberg; Marnie L Peterson; Patrick M Schlievert; David M Kranz
Journal:  Nat Med       Date:  2007-05-21       Impact factor: 53.440

4.  Prevalence of serum antibodies to toxic-shock-syndrome-toxin-1 and to staphylococcal enterotoxins A, B and C in West-Germany.

Authors:  E Schröder; G Kunstmann; H Hasbach; G Pulverer
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-11

5.  Immunochemical assays for toxic shock syndrome toxin-1.

Authors:  P M Schlievert
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

6.  Lack of muco-cutaneous signs of toxic shock syndrome when T cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma.

Authors:  N S Kamel; M C Banks; A Dosik; D Ursea; A A Yarilina; D N Posnett
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  Nonmenstrual toxic shock syndrome: a review of 130 cases.

Authors:  A L Reingold; N T Hargrett; B B Dan; K N Shands; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  Molecular analysis of staphylococcal superantigens.

Authors:  Patrick M Schlievert; Laura C Case
Journal:  Methods Mol Biol       Date:  2007

9.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

10.  Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells.

Authors:  Yoshio Matsuda; Hidehito Kato; Ritsuko Yamada; Hiroya Okano; Hiroaki Ohta; Ken'ichi Imanishi; Ken Kikuchi; Kyouichi Totsuka; Takehiko Uchiyama
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883
  10 in total
  9 in total

1.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

2.  Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Eric V Marietta; Tsung-Teh Wu; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Bacterial Toxins-Staphylococcal Enterotoxin B.

Authors:  Bettina C Fries; Avanish K Varshney
Journal:  Microbiol Spectr       Date:  2013-12

4.  Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease.

Authors:  D M Mattis; A R Spaulding; O N Chuang-Smith; E J Sundberg; P M Schlievert; D M Kranz
Journal:  Protein Eng Des Sel       Date:  2012-11-15       Impact factor: 1.650

Review 5.  Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Authors:  Amanda J Brosnahan; Patrick M Schlievert
Journal:  FEBS J       Date:  2011-05-19       Impact factor: 5.542

Review 6.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

Review 7.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

8.  Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Marah Holz; Tsung-Teh Wu; Chella S David; Govindarajan Rajagopalan
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

Review 9.  Soluble T cell receptor Vβ domains engineered for high-affinity binding to staphylococcal or streptococcal superantigens.

Authors:  Preeti Sharma; Ningyan Wang; David M Kranz
Journal:  Toxins (Basel)       Date:  2014-01-28       Impact factor: 4.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.